Skip to main content
Anthony Magliocco, MD, Pathology, Orlando, FL

AnthonyMMaglioccoMDFRCPC FCAP

Pathology Orlando, FL

Molecular Genetics, Anatomic Pathology, Surgical Pathology

CEO & President, Protean BioDiagnostics

Dr. Magliocco is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Magliocco's full profile

Already have an account?

Summary

  • Dr. Anthony Magliocco is CEO and Medical Director of Protean BioDiagnostics. As former Chair of Pathology at Moffitt Cancer Center he has extensive expertise in precision oncology and molecular diagnostics with subspecialty expertise in breast and gyne pathology as well as translational research. He has published over 200 research manuscripts and holds numerous patents. He holds Professorships in Oncology and Pathology at both USF and the University of Calgary. His focus is in companion diagnostics, precision oncology, digital pathology, and advanced diagnostics including liquid biopsy and artificial intelligence.
  • PROTEAN MAPS- Closing the GAPS in Cancer Diagnostics

    Oncology MAPS is a complete molecular and genetic profiling system designed to close the GAPS in patient diagnosis and management

    The Cancer Informant- Dedicated to Patients

    Cancer Informant is a podcast that was born out of a desire to help inform cancer patients and their loved ones about their options for testing and treatment.

    Protean BioDiagnostics for Precision Oncology

    Protean BioDiagnostics is making access to precision oncology diagnostics easy for all physicians

    Protean BioDiagnostics

    Every cancer is unique, and requires individualized treatment. The right treatment depends on accurate and complete pathology tests. We help patients navigate t

Education & Training

  • University of Alberta
    University of AlbertaClass of 1987
  • University of Lethbridge
    University of LethbridgeB.S., Biological Sciences, Chemistry, 1983
  • University of Lethbridge
    University of LethbridgeB.S., Major in Biological Sciences, minor in Chemistry, 1983

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2011 - 2025
  • PA State Medical License
    PA State Medical License 1991 - 1993
  • American Board of Pathology Anatomic Pathology

Awards, Honors, & Recognition

  • ASTRO Annual Meeting Award, "PS6 Status is an Independent Predictor of Survival in Locally Advanced Cervical Cancer Patients Treated with Chemoradiotherapy: A Canadian Translational Research Multicenter Clinicopathologic Study" 2010
  • Overall Academic Excellence Award University of Calgary, Department of Oncology, 2009
  • Overall Academic Excellence Award University of Calgary, 2009
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Identification of Nine New Susceptibility Loci for Endometrial Cancer  
    Gloria E Sarto, Stephen J Chanock, Anthony M Magliocco, Nature
  • Utility of digital image analysis in the identification of tall call variant of papillary thyroid carcinoma (TCV-PTC): Are we ready for the next step?  
    Hernandez-Prera, J.C., Urken, M.L., Xiong, Y., Johnson, J., Kasprzak, A., Bui, M., Magliocco, A. and Wenig, B., Modern Pathology, 1/1/2018
  • Female Chromosome X Mosaicism Is Age-Related and Preferentially Affects the Inactivated X Chromosome  
    Chu Chen, J Michael Gaziano, Robert C Kurtz, Anthony M Magliocco, Amy Hutchinson, Robert R McWilliams, Nature
  • Join now to see all

Abstracts/Posters

  • HPV Genotyping of Penile Carcinomas by Real-Time Polymerase Chain Reaction (qPCR) and Multi-color Melting Curve Analysis (MMCA) of formalin fixed paraffin embedded (FF...
    Gadara M., Kothapalli R., Magliocco G., Spiess PE., Magliocco AM., Dhillon J., USCAP Annual Meeting, Vancouver, British Cloumbia, Canada, 1/17/2018
  • Analysis of Gene Expression and Mutations Involved in Epigenetic Regulation of Endometrial Carcinoma
    Gadara, M., Toruner, G., Teer, J.K., Xiong, Y., Welsh, E.A., Zhang, Y.O., Magliocco, A. and Saglam, O., Modern Pathology, 1/1/2018
  • Leveraging Digital Pathology to Identify Biomarkers in Ewing Sarcoma
    Saeed-Vafa, D., Brohl, A.S., Xiong, Y., Magliocco, A. and Bui, M., Modern Pathology, 1/1/2018
  • Join now to see all

Lectures

  • Bringing Digital Pathology to the CLIA Laboratory: The Moffitt Experience 
    Vancouver, British Columbia, Canada - 1/17/2018
  • Implementing Personalized oncology and impacts on pathology: The Moffitt Cancer Center Experience 
    St. Augustine, FL - 1/28/2017
  • Emerging Data on Bladder Preservation 
    San Diego, CA - 1/27/2017
  • Join now to see all

Other

  • Ovarian Serous Cancer Study 
    Magliocco AM, Bay News 9, Moffitt Cancer Center
    1/1/2016
  • Breast Cancer Diagnostics: Present and future in the AP lab. 
    Magliocco A
    Tampa, FL. - 1/16/2013
  • Walk provides troops for cancer fight, funds used to buy cutting-edge technology. 
    Goldman S, Calgary Herald, Interview
    7/17/2007
  • Join now to see all

Authored Content

  • Managing the Explosion of Biomarkers in Oncology7/7/2018

Press Mentions

  • Two New Experts Join the Diaceutics Advisory Panel
    Two New Experts Join the Diaceutics Advisory PanelSeptember 8th, 2021
  • A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and Cancer
    A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and CancerMarch 13th, 2021
  • Diaceutics Launches World’s First Diagnostic Network for Precision Medicine to Solve Global Cancer Testing Issues
    Diaceutics Launches World’s First Diagnostic Network for Precision Medicine to Solve Global Cancer Testing IssuesOctober 28th, 2020
  • Join now to see all